| Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma A Arbelaiz, M Azkargorta, M Krawczyk, A Santos‐Laso, A Lapitz, ... Hepatology 66 (4), 1125-1143, 2017 | 267 | 2017 |
| Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma, and primary sclerosing cholangitis JM Banales, M Iñarrairaegui, A Arbelaiz, P Milkiewicz, J Muntané, ... Hepatology 70 (2), 547-562, 2019 | 132 | 2019 |
| Methods for extracellular vesicles isolation in a hospital setting M Sáenz-Cuesta, A Arbelaiz, A Oregi, H Irizar, I Osorio-Querejeta, ... Frontiers in immunology 6, 50, 2015 | 124 | 2015 |
| Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage MJ Perugorria, A Esparza-Baquer, F Oakley, I Labiano, A Korosec, A Jais, ... Gut 68 (3), 533-546, 2019 | 103 | 2019 |
| MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation O Erice, P Munoz‐Garrido, J Vaquero, MJ Perugorria, ... Hepatology 67 (4), 1420-1440, 2018 | 98 | 2018 |
| Role of TGR5 (GPBAR1) in liver disease V Keitel, D Häussinger Seminars in liver disease 38 (04), 333-339, 2018 | 83 | 2018 |
| Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression O Erice, I Labiano, A Arbelaiz, A Santos-Laso, P Munoz-Garrido, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 73 | 2018 |
| Patients with cholangiocarcinoma present specific RNA profiles in serum and urine extracellular vesicles mirroring the tumor expression: novel liquid biopsy biomarkers for … A Lapitz, A Arbelaiz, CJ O’Rourke, JL Lavin, A La Casta, C Ibarra, ... Cells 9 (3), 721, 2020 | 70 | 2020 |
| Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases AD Urribarri, P Munoz-Garrido, MJ Perugorria, O Erice, ... Gut 63 (10), 1658-1667, 2014 | 64 | 2014 |
| MicroRNAs and extracellular vesicles in cholangiopathies P Olaizola, PY Lee-Law, A Arbelaiz, A Lapitz, MJ Perugorria, L Bujanda, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 55 | 2018 |
| MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis D Fernández-Ramos, P Fernández-Tussy, F Lopitz-Otsoa, ... Cell death & disease 9 (10), 958, 2018 | 46 | 2018 |
| Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma J Vaquero, F Judée, M Vallette, H Decauchy, A Arbelaiz, L Aoudjehane, ... Cancers 12 (5), 1280, 2020 | 45 | 2020 |
| Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma A Lapitz, M Azkargorta, P Milkiewicz, P Olaizola, E Zhuravleva, ... Journal of hepatology 79 (1), 93-108, 2023 | 36 | 2023 |
| Extracellular vesicles in hepatobiliary malignancies A Lapitz, A Arbelaiz, P Olaizola, A Aranburu, L Bujanda, MJ Perugorria, ... Frontiers in immunology 9, 365094, 2018 | 35 | 2018 |
| Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: new therapeutic targets A Santos‐Laso, L Izquierdo‐Sanchez, PM Rodrigues, BQ Huang, ... Liver International 40 (7), 1670-1685, 2020 | 27 | 2020 |
| Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling C Lobe, M Vallette, A Arbelaiz, E Gonzalez‐Sanchez, L Izquierdo, A Pellat, ... Hepatology 74 (6), 3194-3212, 2021 | 18 | 2021 |
| Numerical simulation of mass transfer dynamics in Taylor flows C Butler, E Cid, AM Billet, B Lalanne International Journal of Heat and Mass Transfer 179, 121670, 2021 | 18 | 2021 |
| Molecular mechanisms of cholangiocarcinogenesis: new potential targets for therapy O Erice, M Merino-Azpitarte, A Arbelaiz, M Gutierrez-Larranaga, ... Current drug targets 18 (8), 932-949, 2017 | 13 | 2017 |
| Methods for extracellular vesicles isolation in a hospital setting. Front Immunol. 2015; 6: 50 M Sáenz-Cuesta, A Arbelaiz, A Oregi, H Irizar, I Osorio-Querejeta, ... | 8 | 2015 |
| Genetic alterations shaping tumor response to anti-EGFR therapies J Vaquero, A Pavy, E Gonzalez-Sanchez, M Meredith, A Arbelaiz, ... Drug Resistance Updates 64, 100863, 2022 | 5 | 2022 |
